Showing results (91-100 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|May 25, 2004
Risk management from an Asian/Pacific Rim regulatory perspectiveJohn McEwen
Drug Safety|May 25, 2004
The periodic safety update report as a pharmacovigilance toolMichael J Klepper
Drug Safety|May 25, 2004
Managing the interface with marketing to improve delivery of pharmacovigilance within the pharmaceutical industryBrian Edwards
Drug Safety|April 28, 2005
The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?I Ralph Edwards
Drug Safety|April 28, 2005
Benefit-risk assessment of irinotecan in advanced colorectal cancerBengt Glimelius
Drug Safety|April 28, 2005
Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring ProgrammeMira Harrison-Woolrych, Peter Herbison, Rachael McLean, et al.
Drug Safety|April 28, 2005
Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory valuesSteffen Haffner, Nicoletta von Laue, Stefan Wirth, et al.
Drug Safety|January 15, 2005
Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practiceYen-Fu Chen, Anthony J Avery, Karen E Neil, et al.
Drug Safety|January 15, 2005
Effect of information on reported adverse events in a placebo-controlled trialMichael Ossege, Thomas Sycha, Martin Aigner, et al.
Drug Safety|December 14, 2004
Drug-induced immune thrombocytopeniaPatricia M L A van den Bemt, Ronald H B Meyboom, Antoine C G Egberts
Pageof 308